Aneka Jaringan Holdings Berhad (KLSE:ANEKA)
Malaysia · Delayed Price · Currency is MYR 0.1350
-0.0050 (-3.57%)
At close: Aug 1, 2025
Revance Therapeutics Market Cap
KLSE:ANEKA has a market cap or net worth of 93.76 million as of August 1, 2025. Its market cap has decreased by -21.58% in one year.
Market Cap
93.76M
Enterprise Value
135.86M
Revenue
252.46M
Ranking
n/a
PE Ratio
21.45
Stock Price
$0.14
Market Cap Chart
Since October 20, 2020, KLSE:ANEKA's market cap has decreased from 156.05M to 93.76M, a decrease of -39.92%. That is a compound annual growth rate of -10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 93.76M | -16.18% |
| Dec 31, 2024 | 111.85M | -9.80% |
| Dec 29, 2023 | 124.01M | 39.66% |
| Dec 30, 2022 | 88.79M | -17.50% |
| Dec 31, 2021 | 107.62M | -42.86% |
| Dec 31, 2020 | 188.34M | 20.69% |
| Oct 20, 2020 | 156.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Malayan Banking Berhad | 115.98B |
| Public Bank Berhad | 82.85B |
| Tenaga Nasional Berhad | 77.53B |
| CIMB Group Holdings Berhad | 73.03B |
| IHH Healthcare Berhad | 59.04B |
| Celcomdigi Berhad | 44.70B |
| Press Metal Aluminium Holdings Berhad | 43.92B |
| Hong Leong Bank Berhad | 39.24B |